• COVID-19
  • Allergies and Infant Formula
  • Pharmacology
  • Telemedicine
  • Drug Pipeline News
  • Influenza
  • Allergy, Immunology, and ENT
  • Autism
  • Cardiology
  • Emergency Medicine
  • Endocrinology
  • Adolescent Medicine
  • Gastroenterology
  • Infectious disease
  • Nutrition
  • Neurology
  • Obstetrics-Gynecology & Women's Health
  • Developmental/Behavioral Disorders
  • Practice Improvement
  • Gynecology
  • Respiratory
  • Dermatology
  • Diabetes
  • Mental Health
  • Oncology
  • Psychiatry
  • Animal Allergies
  • Alcohol Abuse
  • Rheumatoid Arthritis
  • Sexual Health
  • Pain

On the Tip of Her Tongue

Consultant for PediatriciansConsultant for Pediatricians Vol 6 No 9
Volume 6
Issue 9

These lesions on the tongue of a 7-year-old white girl had been present since she was 2. Her physician at that time had diagnosed "geographic tongue." Over the years, the lesions have increased in number, although not in size.

These lesions on the tongue of a 7-year-old white girl had been present since she was 2. Her physician at that time had diagnosed "geographic tongue." Over the years, the lesions have increased in number, although not in size.

The vesicular lesions measure a few millimeters to a centimeter in diameter and are mostly reddish; a few are blue. They are asymptomatic. Minimal bleeding occurs with trauma. The child has no other skin lesions and has been otherwise healthy. Her birth history and family history are unremarkable.

Hemangiomas and vascular, lymphatic, and arteriovenous malformations were considered in the differential diagnosis. Based on my clinical impression, I believe the diagnosis is multiple hemangiolymphangiomas of the tongue. Do you agree with this assessment?

Would you consider a diagnostic study, imaging, or biopsy for this patient? Could you comment on the prognosis and treatment?

---- Bhagwan Das Bang, MD Opp, Ala

I thank Dr Bang for sharing this most unusual and interesting case with the Consultant readership. Obviously, this young girl's condition does not remotely resemble the flat, curvilinear, red and white lesion typical of geographic tongue.1 Some 40% to 80% of tongue tumors are vascular; the remaining neoplasms are teratomas and hamartomas of various connective tissue elements (eg, nerve and muscle). The multiple, red to purple, bleb-like papules strongly suggest a vascular cause of this long-standing tumor.

Morphology alone does not allow proper subclassification, because such lesions may be variably composed of capillary, venular, arteriolar, or lymphatic channels. Despite the predominantly red color, the entire lesion could actually be a lymphangioma with superimposed capillary leakage. Therefore, I would favor a biopsy of a prominent papule to try to characterize the lesion histologically. Tongue biopsies heal readily and well.

Some attempt should be made to assess the lesion for overall extent and for the possibility of a single "feeding" structure amenable to ligature or embolization. Ultrasonography is a simple noninvasive method that might be entertained. Contrast-enhanced CT scans might also be considered. However, the best diagnostic technique for tongue lesions is probably MRI. Axial, coronal, and sagittal views should be obtained with T1-, T2-, and T1-gadolinium enhancement.

If there is no single large, deep anomaly, then individual blebs could be electrocauterized and/or high-density bleb-bearing areas could be removed en bloc by partial glossectomy.2

I would be concerned about the possible development of macroglossia and would certainly wonder about the psychosocial ramifications of an atypical-appearing tongue. Thus, for both medical and cosmetic reasons, I think that intervention is justifiable.

---- Ted Rosen, MD Professor of Dermatology Baylor College of Medicine Houston




Nuthakki S, Schlievert R. Geographic tongue.

Consultant For Pediatricians.



Jian XC. Surgical management of lymphangiomatous or lymphangiohemangiomatous macroglossia.

J Oral Maxillofac Surg.


Related Videos
Lawrence Eichenfield, MD
Lawrence Eichenfield, MD | Image credit: KOL provided
FDA approves B-VEC to treat dystrophic epidermolysis bullosa patients 6 months and older | Image Credit: bankrx - Image Credit: bankrx - stock.adobe.com.
Related Content
© 2024 MJH Life Sciences

All rights reserved.